Bicycle Therapeutics Plc (BCYC)
3.685
-0.04
(-1.21%)
USD |
NASDAQ |
Sep 25, 16:00
3.68
0.00 (0.00%)
After-Hours: 19:59
Bicycle Therapeutics Cash and Short Term Investments (Annual) : 628.66M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 628.66M |
| December 31, 2024 | 879.52M |
| December 31, 2023 | 526.42M |
| December 31, 2022 | 339.15M |
| December 31, 2021 | 438.68M |
| Date | Value |
|---|---|
| December 31, 2020 | 135.99M |
| December 31, 2019 | 92.12M |
| December 31, 2018 | 63.38M |
| December 31, 2017 | 67.66M |
| December 31, 2016 | 9.402M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Autolus Therapeutics Plc | 302.21M |
| Akari Therapeutics Plc | 5.263M |
| Cellectis SA | 208.66M |
| Biodexa Pharmaceuticals Plc | 11.48M |
| Mereo BioPharma Group Plc | 40.99M |